BASF Shares Walk a Tightrope Between Bullish Bank Calls and a Flurry of Operational Moves
Published on 08/24/2026 at 02:52 | Redaktion boerse-global.de
The Ludwigshafen-based chemicals giant is sending mixed signals to the market these days. On one hand, its stock is trading comfortably above key technical averages and Deutsche Bank Research has slapped a €60 price target on the shares. On the other, JPMorgan downgraded the stock to "Underweight" just over a week ago, leaving investors to puzzle over which reading of the company is closer to the truth.
The divergence in analyst opinion is striking. Deutsche Bank Research reaffirmed its "Buy" rating on August 12 with a €60 target — a level that implies meaningful upside from current prices. JPMorgan had moved in the opposite direction on August 4, cutting its stance to "Underweight." Sandwiched between those two poles, Berenberg confirmed its "Hold" recommendation in late July while nudging its price objective from €47 to €50, though that call is now several weeks old and carries less weight as a fresh signal.
A Flurry of Commercial Activity
While the equity research community debates the stock's fair value, BASF has been quietly busy on the operational front. On August 12, the company announced price increases across Europe for two specialty chemicals: €250 per metric ton for neopentyl glycol and €300 per metric ton for 1,6-hexanediol, effective immediately or as contracts permit. The very next day, it followed with a similar move in North America, raising neopentyl glycol prices by $0.10 per pound (or $221 per metric ton) in the U.S. and Canada, effective September 1 or per contract terms.
The coordinated pricing action on both sides of the Atlantic suggests BASF is looking to pass on rising industry-wide costs without ceding ground in any particular region. That pricing discipline is being paired with a visible push into innovation. The Agricultural Solutions division announced plans on August 12 to build a new Climate Center at its headquarters, and a day later unveiled xarvio CONNECT 2.0, a next-generation portable hardware device for the North American farming market. In the personal care segment, the company introduced Floragenist™, a new line of floral-based active ingredients, on August 11.
Should investors sell immediately? Or is it worth buying BASF?
Most recently, BASF opened a global performance lab in Mumbai dedicated to diapers and superabsorbents, adding technical and application-specific services for customers worldwide. The move underscores a strategy of backing up sales efforts in growth markets like India with physical infrastructure rather than relying on distribution alone.
Buyback Machine Humming Along
Amid the operational announcements, the share repurchase program continues to tick forward. In its second interim report on August 17, BASF disclosed that it bought back 695,000 of its own shares between August 10 and 14, following 545,000 shares acquired in the first reporting week from August 3 to 7. That brings the cumulative volume since the program's start on August 3 to 1,240,000 shares. The August 10 purchases were executed on XETRA and TQEX at volume-weighted average prices of €51.4858 and €51.4354 per share, respectively — levels close to where the stock currently trades.
Political Tailwinds and Technical Signals
Adding another layer to the story, comments from Katherina Reiche roughly ten days ago about potential reforms to the emissions trading system drew attention to the stock. For an energy-intensive producer like BASF, policy signals on carbon pricing carry particular weight, even though no concrete corporate decision from the company has emerged on the matter. Whether those political signals translate into actual regulatory relief for the chemicals industry could prove decisive in validating the more optimistic analyst forecasts.
The chart, however, tells a story of consolidation rather than conviction. The shares closed Friday at €51.60, up 0.5 percent on the day. Over the past 30 days, the stock has gained 6.2 percent, and it is up 16 percent since the start of the year. That leaves it 6.3 percent below its 52-week high of €55.05, reached in April. The stock sits comfortably above its 200-day moving average of €48.48 and roughly 4.8 percent above its 50-day average of €49.22. The relative strength index at 59.4 points to neither overbought nor oversold conditions — rather, a market catching its breath after a strong run.
For shareholders, the takeaway is a familiar one: the fundamental debate over BASF's valuation remains unresolved. Those siding with Deutsche Bank Research see clear headroom to the €60 target. Those inclined toward JPMorgan's caution will likely view further upside with skepticism. What could tip the balance is whether Berlin's signals on emissions trading harden into concrete regulatory changes — a development that would lend considerable weight to the bullish camp.
Ad
BASF Stock: New Analysis - 24 August
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
